Search

The Tu Lab applies an integrative approach that combines stem cells, tissue engineering, molecular biology, and multiomics technologies to study acquired and genetic cardiac disorders, with the ultimate goal of developing precision medicine for heart disease. 

Learn about the Burgess Lab's research

Skip to main content About Us Built on a quarter-century of research in mood disorders, the Center for Depression Research and Clinical Care (CDRC) was established in 2015 to realize a future free from the burden of depression. In the last seven years, our Center has demonstrated its impact in lives changed. We have led research into new treatments, including brain and blood tests, for depression and suicide. Our Vision A future free from the burden of depression. Our Mission Transform the

Learn about Mason Lab's Novel Reporter Agents research.

Cross-section of engineered heart tissue derived from iPSCs stained for troponin (green) and nuclei (blue). Cells formed an aligned structure, mimicking the architecture of human myocardium.

Learn more about the ANSIR Lab's research on traumatic brain injuries.

Skip to main content Depression Research Our Clinical Trials Depression is a major health challenge affecting more than 300 million people globally. Research suggests that 1 in 6 people will experience depression in their lifetime with an 18% increase over the past decade. Of the more than 17 million individuals diagnosed with depression living in the United States, more than 5 million experience treatment-resistant depression. Many of our trials focus on those individuals struggling with

Get to know our Principal Investigator and team of researchers at Jin Jiang Lab  

Skip to main content Resilience and Suicidal Ideation Research Because depression often begins early in life, our goal is to proactively study the disease in young people to ultimately prevent or minimize its impact population-wide. To further this goal of reducing adolescent suicidality, our team has received two grants from the American Foundation for Suicide Prevention (AFSP) and the National Institute of Mental Health (NIMH). RAD Resilience Against Depression Study A longitudinal

Skip to main content Research Our laboratory is dedicated to developing and translating innovative ultrasound platforms and contrast agents for clinical use, with the ultimate goal of improving patient care. Phase-Shift Ultrasound Contrast Agents Tissue-Mimicking Phantom for Liver Fat Quantification